Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy.
D002277:Carcinoma / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy*; D002460:Cell Line; D002470:Cell Survival; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005347:Fibroblasts / Q000276:immunology; D005500:Follow-Up Studies; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D008168:Lung / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology / Q000528:radiation effects*; D008297:Male; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011830:Radiation Effects; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy*